Literature DB >> 8375731

Endovaginal scanning of the endometrium compared to cytology and histology in women with postmenopausal bleeding.

B Karlsson1, S Granberg, M Wikland, W Ryd, A Norström.   

Abstract

Endovaginal scanning (EVS) of the endometrium has recently been proposed as a method for the investigation of the endometrial mucosa. In this study, the specificity and sensitivity of EVS have been compared with endometrial cytology and D&C to discriminate between a normal and pathological endometrium. The study included 105 women who underwent preoperative endovaginal ultrasound investigation, endometrial cytology, and D&C because of postmenopausal bleeding. A specificity of 81% and a sensitivity of 97% in diagnosing morphological alterations by means of endovaginal ultrasound was found. The corresponding figures for cytological evaluation were 81 and 58%, respectively. We conclude that endovaginal ultrasound is a valuable diagnostic instrument for detecting pathological conditions in the uterine mucosa and as sensitive as endometrial cytology or D&C.

Entities:  

Mesh:

Year:  1993        PMID: 8375731     DOI: 10.1006/gyno.1993.1188

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Endometrial sampling and general practice.

Authors:  M Shapley; C W Redman
Journal:  Br J Gen Pract       Date:  1997-06       Impact factor: 5.386

Review 2.  Clinical evaluation of women with PMB. Is it always necessary an endometrial biopsy to be performed? A review of the literature.

Authors:  Marina Dimitraki; Panagiotis Tsikouras; Sophia Bouchlariotou; Alexandros Dafopoulos; Vasileios Liberis; Georgios Maroulis; Alexander Tobias Teichmann
Journal:  Arch Gynecol Obstet       Date:  2010-08-04       Impact factor: 2.344

Review 3.  Bias associated with delayed verification in test accuracy studies: accuracy of tests for endometrial hyperplasia may be much higher than we think!

Authors:  T Justin Clark; Gerben ter Riet; Aravinthan Coomarasamy; Khalid S Khan
Journal:  BMC Med       Date:  2004-05-11       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.